Cargando…
A Novel Histone Deacetylase Inhibitor Exhibits Antitumor Activity via Apoptosis Induction, F-Actin Disruption and Gene Acetylation in Lung Cancer
BACKGROUND: Lung cancer is the leading cause of cancer mortality worldwide, yet the therapeutic strategy for advanced non-small cell lung cancer (NSCLC) is limitedly effective. In addition, validated histone deacetylase (HDAC) inhibitors for the treatment of solid tumors remain to be developed. Here...
Autores principales: | Tang, Yen-An, Wen, Wei-Ling, Chang, Jer-Wei, Wei, Tzi-Tang, Tan, Yi-Hung Carol, Salunke, Santosh, Chen, Chien-Tien, Chen, Ching-Shih, Wang, Yi-Ching |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939045/ https://www.ncbi.nlm.nih.gov/pubmed/20856855 http://dx.doi.org/10.1371/journal.pone.0012417 |
Ejemplares similares
-
Mitochondrial Apoptosis and FAK Signaling Disruption by a Novel Histone Deacetylase Inhibitor, HTPB, in Antitumor and Antimetastatic Mouse Models
por: Shieh, Jiunn-Min, et al.
Publicado: (2012) -
Acetylation and Histone Deacetylase Inhibitors in Cancer
por: Kortenhorst, Madeleine S. Q., et al.
Publicado: (2006) -
Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways
por: Chen, Yi-Jin, et al.
Publicado: (2017) -
Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma
por: Yelton, Caleb J., et al.
Publicado: (2018) -
Histone acetylation and the role of histone deacetylases in normal cyclic endometrium
por: Gujral, Palak, et al.
Publicado: (2020)